SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Applied DNA Sciences, Inc. (APDN) .
本页证实的标准:
- VALUE (10/100, 未通过) — 分析师共识目标价暗示当前价格存在下行风险 ($1.50, 73.3%).
- 分析师共识目标价 $1.50 (-73.3% 下行风险) — 分析师认为当前价格水平存在明显下行风险。
SharesGrow 综合评分： 24/100 其中 0/7 项标准通过。
SharesGrow 7-Criteria Score
✗
价值
10/100
Price-to-Earnings & upside
Proven by this page
~
健康
50/100
Debt-to-Equity & liquidity
→ Health
估值概览 — APDN
估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率1.36
EV/EBITDA0.0
每股数据
EPS (TTM)$-134.23
每股账面价值$0.00
每股营收$4.13
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%
分析师目标价$1.50 (-73.3%)
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2016 |
$-411.13 |
$4.19M |
$-12.18M |
-290.8% |
| 2017 |
$-389.88 |
$4.75M |
$-12.86M |
-270.6% |
| 2018 |
$-317.12 |
$3.9M |
$-11.69M |
-299.6% |
| 2019 |
$-187.30 |
$5.39M |
$-8.63M |
-160.2% |
| 2020 |
$-65.14 |
$1.93M |
$-12.76M |
-660.9% |
| 2021 |
$-46.35 |
$9.03M |
$-16.03M |
-177.6% |
| 2022 |
$-18.68 |
$18.17M |
$-8.38M |
-46.1% |
| 2023 |
$-15.21 |
$13.37M |
$-9.95M |
-74.4% |
| 2024 |
$-1.82 |
$3.43M |
$-6.99M |
-203.8% |
| 2025 |
$-134.23 |
$2.14M |
$-69.49M |
-3251.7% |
